Future Perspective
Randomized clinical trials are needed in the pediatric population with vitamin D deficiency to evaluate outcomes including insulin resistance, blood pressure and others. No doubt in the next 5 to 10 years some of these trials will have been conducted and the field will have greater evidence about the associations described in this review.
Financial & competing interests disclosure
Michal L Melamed is supported by grant NIH/NIDDK K23 078774. Juhi Kumar is supported by grant NIH/NIDDK K23 084339. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.
Pediatr Health. 2010;4(1):89-97. © 2010 Future Medicine Ltd.
Cite this: Low Levels of 25-hydroxyvitamin D in the Pediatric Populations: Prevalence and Clinical Outcomes - Medscape - Feb 01, 2010.
Comments